Dan Li Source Confirmed
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
National Center for Toxicological Research
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Dan Li's research investigates molecular biology techniques and their applications in precision medicine and toxicology. His work includes evaluating the analytical validity of circulating tumor DNA sequencing assays for oncology and assessing tumor mutational burden estimation by targeted panel sequencing. Li also studies gene regulation in the context of neurodevelopmental disorders, specifically Autism Spectrum Disorder, utilizing single-cell RNA sequencing and spatial transcriptomics. He has also published on augmenting precision medicine through targeted RNA-Seq detection of expressed mutations and on developing flow cytometry panels for immunoprofiling. His scholarship metrics include an h-index of 3, with 12 publications and 273 citations. Key collaborators include Binsheng Gong and Joshua Xu from the National Center for Toxicological Research, Donald J. Johann from the University of Arkansas for Medical Sciences, and Mary Qu Yang from the University of Arkansas at Little Rock.
Metrics
- h-index: 3
- Publications: 12
- Citations: 273
Selected Publications
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations (2025) DOI
- Assessments of tumor mutational burden estimation by targeted panel sequencing: A comprehensive simulation analysis (2023) DOI
- Single-cell RNA-sequencing and subcellular spatial transcriptomics facilitate the translation of liver microphysiological systems for regulatory application (2023) DOI
- Transcriptomic Response of Human Nosocomial Pathogen Pseudomonas aeruginosa Biofilms Following Continuous Exposure to Antibiotic-Impregnated Catheters (2022) DOI
- Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development (2021) DOI
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology (2021) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics